Role of remote ischemic conditioning in necrotizing enterocolitis

Necrotizing enterocolitis (NEC) is a life-threatening inflammatory intestinal disorder predominantly affecting preterm infants, with a high mortality and morbidity rate. The pathophysiology of NEC is intimately linked to immaturity of the intestinal vasculature and derangements in microcirculatory perfusion, rendering the developing bowel susceptible to ischemic injury following enteral feeding. Remote ischemic conditioning (RIC) is a non-invasive maneuver involving brief cycles of limb ischemia and reperfusion, which engages endogenous cytoprotective mechanisms that can be transmitted to distant organs, including the intestine. This review examines the scientific basis and clinical trajectory of RIC as a therapeutic strategy in NEC. In preclinical models, RIC administered during the early stages of NEC counteracted characteristic derangements in intestinal microcirculation, mediated through nitric oxide and hydrogen sulfide signaling, and thereby led to reduced intestinal injury, attenuation of pro-inflammatory cytokines and prolonged survival. These protective effects occurred only before the onset of irreversible mucosal damage. A non-randomized phase I safety study subsequently confirmed, for the first time in infants with NEC, that RIC was safe and produced no adverse complications. To address the knowledge gaps necessary for an efficacy trial, the RIC-NEC phase II feasibility randomized controlled trial is currently ongoing at 15 international centers across 8 countries. This trial evaluates the feasibility of randomizing and delivering masked RIC to eligible neonates within 24 hours of NEC diagnosis. If successful, a future phase III multicenter randomized controlled trial will assess whether RIC can prevent disease progression and improve clinical outcomes in this vulnerable population.

Authors

Institutions

Publication Details

Journal
World Journal of Pediatric Surgery
Published
2026-11-19
DOI
https://doi.org/10.1136/wjps-2026-001251
Primary Topic
Infant Nutrition and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Role of remote ischemic conditioning in necrotizing enterocolitis

Niloofar Ganji, Agostino Pierro, James Park
World Journal of Pediatric Surgery
Infant Nutrition and Health
article

Role of remote ischemic conditioning in necrotizing enterocolitis

Niloofar Ganji, Agostino Pierro, James Park
article en

Abstract

Necrotizing enterocolitis (NEC) is a life-threatening inflammatory intestinal disorder predominantly affecting preterm infants, with a high mortality and morbidity rate. The pathophysiology of NEC is intimately linked to immaturity of the intestinal vasculature and derangements in microcirculatory perfusion, rendering the developing bowel susceptible to ischemic injury following enteral feeding. Remote ischemic conditioning (RIC) is a non-invasive maneuver involving brief cycles of limb ischemia and reperfusion, which engages endogenous cytoprotective mechanisms that can be transmitted to distant organs, including the intestine. This review examines the scientific basis and clinical trajectory of RIC as a therapeutic strategy in NEC. In preclinical models, RIC administered during the early stages of NEC counteracted characteristic derangements in intestinal microcirculation, mediated through nitric oxide and hydrogen sulfide signaling, and thereby led to reduced intestinal injury, attenuation of pro-inflammatory cytokines and prolonged survival. These protective effects occurred only before the onset of irreversible mucosal damage. A non-randomized phase I safety study subsequently confirmed, for the first time in infants with NEC, that RIC was safe and produced no adverse complications. To address the knowledge gaps necessary for an efficacy trial, the RIC-NEC phase II feasibility randomized controlled trial is currently ongoing at 15 international centers across 8 countries. This trial evaluates the feasibility of randomizing and delivering masked RIC to eligible neonates within 24 hours of NEC diagnosis. If successful, a future phase III multicenter randomized controlled trial will assess whether RIC can prevent disease progression and improve clinical outcomes in this vulnerable population.

World Journal of Pediatric SurgeryVol. 9(6)
University of Toronto (CA), Hospital for Sick Children (CA)
Infant Nutrition and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon